CAS: 1346528-50-4; N-(4-Chloropyridin-3-yl)-4-((2,2-Difluorobenzo[d][1,3]Dioxol-5-yl)Methyl)Piperazine-1-Carboxamide

该化合物是一种合成有机化合物,其特征是复杂的分子结构,包括一个管状环,一个和苯并二氧化物组;该化合物具有潜在的药理特性,经常在药用化学和药物开发过程中加以探讨;氯和二氟代基元素的存在表明,它可能具有独特的电子和...

结构式图片

欧盟法规

C&L通报

上下游产品

1-[(2,2-二氟-1,3-苯并二氧杂环戊烷-5-基)-甲基]哌嗪 1-((2,2-Difluorobenzo[d][1,3]Dioxol-5-yl)Methyl)Piperazine 1093211-85-8

合成工艺路线路线简述

    📜2,2-二氟-1,3-苯并二恶茂-5-甲醛置于20% Palladium Hydroxide-Activated Charcoal 吡啶,氢气体系中,用 甲醇,甲苯 用作溶剂,2.0~70.0 °C,101.33 Kpa 条件下,反应 58.5H,反应生成N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺
    参考文献: Modulators Of Fatty Acid Amide Hydrolase[fr] Modulateurs De L'Amide Hydrolase D'Acide Gras
    标题: Modulators Of Fatty Acid Amide Hydrolase[fr] Modulateurs De L'Amide Hydrolase D'Acide Gras
    摘要:描述了4-(2,2-二氟苯并[1,3]二噁英-5-基甲基)-哌嗪-1-羧酸(4-氯吡啶-3-基)-酰胺,该化合物可用作faah调节剂.4-(2,2-二氟苯并[1,3]二噁英-5-基甲基)-哌嗪-1-羧酸(4-氯吡啶-3-基)-酰胺可用于制备药物组合物,并用于治疗由脂肪酰胺水解酶(Faah)活性介导的疾病状态,紊乱和情况,如焦虑,疼痛,炎症,睡眠障碍,进食障碍,能量代谢紊乱和运动障碍(例如多发性硬化).还公开了合成4-(2,2-二氟苯并[1,3]二噁英-5-基甲基)-哌嗪-1-羧酸(4-氯吡啶-3-基)-酰胺的方法.

    海关参考信息

    专利信息


    专利号:US-12194020-B2
    优先权日:2017-12-22
    标 题:Reversing baldness through cannabinoid receptor activation
    发明人:POSTREL RICHARD
    权利人:POSTREL RICHARD
    摘要:This invention reverses male pattern baldness by shocking dormant hair follicles out of their androgen induced hibernation phase back to the active hair-growing anagenic phase. The invention integrates two functions: 1) It blocks synthesis of compounds holding the follicles in the telogenic/hibernating phase and 2) It stimulates synthesis of compounds animating the hair-growing/anagenic phase in the follicular activity cycle. One preferred embodiment comprises an enzyme inhibitor blocking the conversion of testosterone to dihydrotestosterone (DHT), a flavonoid simultaneously increasing synthesis of prostaglandins alternative to prostaglandin D2, and a selected cannabinoid compound stimulating restore the hair follicle to its normal growth cycle. This novel trimodal therapy restores the hair follicles to their normal cycling processes and maintains these restorative properties so long as this rebalance in maintained.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    John M. Keith,* William M. Jones, Mark Tichenor, Jing Liu, Mark Seierstad, James A. Palmer, Michael Webb, Mark Karbarz, Brian P. Scott, Sandy J. Wilson, Lin Luo, Michelle L. Wennerholm, Leon Chang, Michele Rizzolio, Raymond Rynberg, Sandra R. Chaplan, and J. Guy Breitenbucher. Preclinical Characterization of the FAAH Inhibitor JNJ-42165279, ACS Med. Chem. Lett. Articles ASAP (As Soon As Publishable), Publication Date (Web): November 2, 2015 (Letter), DOI: 10.1021/acsmedchemlett.5b00353

    合成参考文献


    参考文献:10.1038/s41386-020-00888-1
    摘要:Schmidt ME, Liebowitz MR, Stein MB, Grunfeld J, Van Hove I, Simmons WK, Van Der Ark P, Palmer JA, Saad ZS, Pemberton DJ, Van Nueten L, Drevets WC. The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study. Neuropsychopharmacology. 2020 Oct 18;46(5):1004–10. doi: 10.1038/s41386-020-00888-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知